FDA Adverse Event Injury Summary report: N

GMK REVISION TOTAL KNEE SYSTEM

MDR report key: 23153129 · Received September 26, 2025

Report

Report Number
3005180920-2025-00893
Event Type
Injury
Date Received
September 26, 2025
Date of Event
June 11, 2022
Report Date
September 26, 2025
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
PMA / PMN Number
K123721
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON (B)(6) 2025. 02.07.0683R REVISION TIBIAL TRAY SIZE 3 RIGHT - FINISHING (K123721) LOT 186398: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 29-OCT-2018 EXPIRATION DATE: 2023-OCT-18. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. ADDITIONAL DEVICE INVOLVED IN THE EVENT: 02.07.2402R FEMUR REVISION PS CEMENTED S.2R (K102437) LOT 148060: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 02-DEC-2014 EXPIRATION DATE: 2019-OCT-31. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. CONCLUSIONS: ASEPTIC LOOSENING IS A POSSIBLE LITERATURE-DESCRIBED ADVERSE EVENT AFTER PRIMARY KNEE ARTHROPLASTIES AND CAUSES ARE OFTEN UNKNOWN. THERE IS NO INDICATION THAT ANY POTENTIAL ISSUE WITH THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT. NO PREVIOUS CASE HAS BEEN ADDRESSED TO A DEVICE DESIGN OR MANUFACTURING RELATED ROOT CAUSE.

Description of Event or Problem · 0

IN 2014 PATIENT UNDERWENT PRIMARY TKA, DETAILS UNKNOWN. IN 2019 PATIENT UNDERWENT REVISION SURGERY AND GMK-REVISION DEVICES WERE IMPLANTED. IN (B)(6) 2022 ALL GMK-REVISION IMPLANTS WERE REVISED DUE TO MOBILIZATION; IT IS UNKNOWN WHICH IMPLANT WAS MOBILIZED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
311335 GMK REVISION TOTAL KNEE SYSTEM REVISION FIXED TIBIAL TRAY CEMENTED RIGHT, SIZE 3 JWH MEDACTA INTERNATIONAL SA 02.07.0683R 186398

Patients

Seq Age Sex Outcome Treatment
1 62 YR Female Required Intervention